vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and CPI AEROSTRUCTURES INC (CVU). Click either name above to swap in a different company.
CPI AEROSTRUCTURES INC is the larger business by last-quarter revenue ($19.4M vs $19.2M, roughly 1.0× Apyx Medical Corp). CPI AEROSTRUCTURES INC runs the higher net margin — 3.6% vs -6.8%, a 10.3% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs -10.8%). CPI AEROSTRUCTURES INC produced more free cash flow last quarter ($-2.1M vs $-2.8M). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs 0.9%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
CPI Aerostructures Inc., known as CPI Aero, is a contract aircraft component manufacturer based in Edgewood, New York.
APYX vs CVU — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $19.4M |
| Net Profit | $-1.3M | $691.8K |
| Gross Margin | 62.6% | 20.3% |
| Operating Margin | 0.1% | 6.4% |
| Net Margin | -6.8% | 3.6% |
| Revenue YoY | 34.7% | -10.8% |
| Net Profit YoY | 71.9% | -28.8% |
| EPS (diluted) | — | $0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $19.4M | ||
| Q3 25 | $12.9M | $19.3M | ||
| Q2 25 | $11.4M | $15.2M | ||
| Q1 25 | $9.4M | $15.4M | ||
| Q4 24 | $14.2M | $21.8M | ||
| Q3 24 | $11.5M | $19.4M | ||
| Q2 24 | $12.1M | $20.8M | ||
| Q1 24 | $10.2M | $19.1M |
| Q4 25 | $-1.3M | $691.8K | ||
| Q3 25 | $-2.0M | $1.1M | ||
| Q2 25 | $-3.8M | $-1.3M | ||
| Q1 25 | $-4.2M | $-1.3M | ||
| Q4 24 | $-4.6M | $971.5K | ||
| Q3 24 | $-4.7M | $749.7K | ||
| Q2 24 | $-6.6M | $1.4M | ||
| Q1 24 | $-7.6M | $168.2K |
| Q4 25 | 62.6% | 20.3% | ||
| Q3 25 | 64.4% | 22.3% | ||
| Q2 25 | 62.3% | 4.4% | ||
| Q1 25 | 60.1% | 10.7% | ||
| Q4 24 | 63.0% | 20.0% | ||
| Q3 24 | 60.5% | 21.7% | ||
| Q2 24 | 61.7% | 24.6% | ||
| Q1 24 | 58.1% | 18.6% |
| Q4 25 | 0.1% | 6.4% | ||
| Q3 25 | -6.5% | 9.1% | ||
| Q2 25 | -22.6% | -13.1% | ||
| Q1 25 | -32.4% | -7.7% | ||
| Q4 24 | -21.4% | 9.5% | ||
| Q3 24 | -31.6% | 7.6% | ||
| Q2 24 | -45.7% | 11.2% | ||
| Q1 24 | -64.6% | 4.4% |
| Q4 25 | -6.8% | 3.6% | ||
| Q3 25 | -15.4% | 5.8% | ||
| Q2 25 | -33.2% | -8.7% | ||
| Q1 25 | -44.0% | -8.6% | ||
| Q4 24 | -32.5% | 4.5% | ||
| Q3 24 | -40.9% | 3.9% | ||
| Q2 24 | -54.0% | 6.8% | ||
| Q1 24 | -74.0% | 0.9% |
| Q4 25 | — | $0.04 | ||
| Q3 25 | — | $0.09 | ||
| Q2 25 | — | $-0.10 | ||
| Q1 25 | — | $-0.10 | ||
| Q4 24 | — | $0.08 | ||
| Q3 24 | — | $0.06 | ||
| Q2 24 | $-0.19 | $0.11 | ||
| Q1 24 | $-0.22 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | — |
| Total DebtLower is stronger | $37.5M | $0 |
| Stockholders' EquityBook value | $14.5M | $25.8M |
| Total Assets | $66.8M | $75.2M |
| Debt / EquityLower = less leverage | 2.58× | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | — | ||
| Q3 25 | $25.1M | — | ||
| Q2 25 | $29.3M | — | ||
| Q1 25 | $31.0M | — | ||
| Q4 24 | $31.7M | — | ||
| Q3 24 | $28.0M | — | ||
| Q2 24 | $32.7M | — | ||
| Q1 24 | $37.3M | — |
| Q4 25 | $37.5M | $0 | ||
| Q3 25 | $37.5M | — | ||
| Q2 25 | $37.5M | — | ||
| Q1 25 | $37.5M | — | ||
| Q4 24 | $37.5M | $26.5K | ||
| Q3 24 | $37.5M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $14.5M | $25.8M | ||
| Q3 25 | $5.8M | $25.0M | ||
| Q2 25 | $7.3M | $23.8M | ||
| Q1 25 | $10.5M | $24.9M | ||
| Q4 24 | $14.2M | $25.9M | ||
| Q3 24 | $11.0M | $24.9M | ||
| Q2 24 | $14.7M | $24.1M | ||
| Q1 24 | $20.3M | $22.5M |
| Q4 25 | $66.8M | $75.2M | ||
| Q3 25 | $57.4M | $74.1M | ||
| Q2 25 | $58.2M | $72.3M | ||
| Q1 25 | $60.2M | $65.4M | ||
| Q4 24 | $64.8M | $68.0M | ||
| Q3 24 | $60.7M | $68.9M | ||
| Q2 24 | $65.4M | $70.2M | ||
| Q1 24 | $70.7M | $70.8M |
| Q4 25 | 2.58× | 0.00× | ||
| Q3 25 | 6.41× | — | ||
| Q2 25 | 5.17× | — | ||
| Q1 25 | 3.57× | — | ||
| Q4 24 | 2.64× | 0.00× | ||
| Q3 24 | 3.40× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $-2.1M |
| Free Cash FlowOCF − Capex | $-2.8M | $-2.1M |
| FCF MarginFCF / Revenue | -14.6% | -10.8% |
| Capex IntensityCapex / Revenue | 1.4% | 0.0% |
| Cash ConversionOCF / Net Profit | — | -3.03× |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | $-5.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $-2.1M | ||
| Q3 25 | $-3.5M | $212.1K | ||
| Q2 25 | $-1.2M | $-596.3K | ||
| Q1 25 | $-702.0K | $-2.7M | ||
| Q4 24 | $-2.9M | $4.4M | ||
| Q3 24 | $-4.4M | $715.1K | ||
| Q2 24 | $-4.3M | $-591.7K | ||
| Q1 24 | $-6.3M | $-960.5K |
| Q4 25 | $-2.8M | $-2.1M | ||
| Q3 25 | $-4.1M | $211.1K | ||
| Q2 25 | $-1.5M | $-599.8K | ||
| Q1 25 | $-757.0K | $-2.8M | ||
| Q4 24 | $-3.2M | $4.3M | ||
| Q3 24 | $-4.6M | $586.9K | ||
| Q2 24 | $-4.6M | $-746.9K | ||
| Q1 24 | $-6.4M | $-1.0M |
| Q4 25 | -14.6% | -10.8% | ||
| Q3 25 | -31.5% | 1.1% | ||
| Q2 25 | -13.2% | -4.0% | ||
| Q1 25 | -8.0% | -18.1% | ||
| Q4 24 | -22.4% | 19.9% | ||
| Q3 24 | -40.0% | 3.0% | ||
| Q2 24 | -38.0% | -3.6% | ||
| Q1 24 | -62.2% | -5.3% |
| Q4 25 | 1.4% | 0.0% | ||
| Q3 25 | 4.0% | 0.0% | ||
| Q2 25 | 2.3% | 0.0% | ||
| Q1 25 | 0.6% | 0.4% | ||
| Q4 24 | 1.7% | 0.3% | ||
| Q3 24 | 1.3% | 0.7% | ||
| Q2 24 | 2.4% | 0.7% | ||
| Q1 24 | 0.3% | 0.2% |
| Q4 25 | — | -3.03× | ||
| Q3 25 | — | 0.19× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 4.53× | ||
| Q3 24 | — | 0.95× | ||
| Q2 24 | — | -0.42× | ||
| Q1 24 | — | -5.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
APYX
Segment breakdown not available.
CVU
| Government Subcontracts | $16.4M | 85% |
| Commercial Contracts | $2.3M | 12% |
| Prime Government Contracts | $725.8K | 4% |
